Stratec (ETR:SBS) Trading Down 0.9% – What’s Next?

Shares of Stratec SE (ETR:SBSGet Free Report) dropped 0.9% during trading on Monday . The stock traded as low as €27.40 ($31.86) and last traded at €27.70 ($32.21). Approximately 10,230 shares were traded during mid-day trading, an increase of 64% from the average daily volume of 6,253 shares. The stock had previously closed at €27.95 ($32.50).

Stratec Stock Down 2.3%

The firm has a market capitalization of $327.97 million, a price-to-earnings ratio of 32.76, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16. The firm’s 50-day moving average price is €25.81 and its 200 day moving average price is €27.57. The company has a debt-to-equity ratio of 66.97, a current ratio of 2.52 and a quick ratio of 1.65.

Stratec Company Profile

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

See Also

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.